首页 > 最新文献

Tzu Chi Medical Journal最新文献

英文 中文
Cell culture platform fabrication methods and applications.
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 eCollection Date: 2026-01-01 DOI: 10.4103/tcmj.TCMJ-D-25-00004
Yao-Nan Wang, Ko-Tung Chang, Jui-Kai Liu, Chang-Hsien Tai

Cell culture technologies are fundamental tool in biological research. Traditional two-dimensional (2D) cell culture methods, despite their widespread use and simplicity, fail to accurately replicate the physiological conditions of native tissues, leading to altered cellular behavior. Recent advancements in 3D culture techniques, combined with innovative fabrication methods such as photolithography, paper-based, and 3D printing, have substantially improved the fidelity of cell culture models. In parallel, numerical simulations have become indispensable for optimizing the design and performance of these systems, offering precise control microenvironmental factors such as fluid dynamics, nutrient and oxygen gradients, and shear stress within microfluidic platforms. These approaches for integration facilitate accurate modeling of cell-to-cell and cell-to-matrix interactions essential for physiological relation. Concurrently, the integration of multimaterial fabrication techniques provides scalable and customizable solutions for developing sophisticated microfluidic and cell culture systems. This review discusses recent developments in these fabrication methods and highlights their integration with numerical simulation for optimization design, explores their collective potential to advance biomedical research and applications.

细胞培养技术是生物学研究的基础工具。传统的二维(2D)细胞培养方法,尽管其广泛使用和简单,但不能准确地复制天然组织的生理条件,导致细胞行为改变。3D培养技术的最新进展,结合创新的制造方法,如光刻、纸质和3D打印,大大提高了细胞培养模型的保真度。与此同时,数值模拟对于优化这些系统的设计和性能也变得必不可少,可以精确控制微环境因素,如流体动力学、营养和氧气梯度以及微流控平台内的剪切应力。这些整合方法有助于对生理关系所必需的细胞与细胞和细胞与基质相互作用进行精确建模。同时,多材料制造技术的集成为开发复杂的微流体和细胞培养系统提供了可扩展和可定制的解决方案。这篇综述讨论了这些制造方法的最新发展,并强调了它们与优化设计的数值模拟的结合,探讨了它们在推进生物医学研究和应用方面的共同潜力。
{"title":"Cell culture platform fabrication methods and applications.","authors":"Yao-Nan Wang, Ko-Tung Chang, Jui-Kai Liu, Chang-Hsien Tai","doi":"10.4103/tcmj.TCMJ-D-25-00004","DOIUrl":"https://doi.org/10.4103/tcmj.TCMJ-D-25-00004","url":null,"abstract":"<p><p>Cell culture technologies are fundamental tool in biological research. Traditional two-dimensional (2D) cell culture methods, despite their widespread use and simplicity, fail to accurately replicate the physiological conditions of native tissues, leading to altered cellular behavior. Recent advancements in 3D culture techniques, combined with innovative fabrication methods such as photolithography, paper-based, and 3D printing, have substantially improved the fidelity of cell culture models. In parallel, numerical simulations have become indispensable for optimizing the design and performance of these systems, offering precise control microenvironmental factors such as fluid dynamics, nutrient and oxygen gradients, and shear stress within microfluidic platforms. These approaches for integration facilitate accurate modeling of cell-to-cell and cell-to-matrix interactions essential for physiological relation. Concurrently, the integration of multimaterial fabrication techniques provides scalable and customizable solutions for developing sophisticated microfluidic and cell culture systems. This review discusses recent developments in these fabrication methods and highlights their integration with numerical simulation for optimization design, explores their collective potential to advance biomedical research and applications.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"21-30"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long noncoding RNA LOC441461 drives cancer growth and is associated with poor clinical outcomes.
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 eCollection Date: 2026-01-01 DOI: 10.4103/tcmj.TCMJ-D-25-00032
Ching-Feng Cheng, Ya-Ting Tu, Yi-Ru Chen, Ming-Cheng Lee, Hui-Chen Ku, Kuo-Wang Tsai

Objectives: The role of LOC441461, a long noncoding RNA, differs in different cancer types, and its role in lung cancer remains unclear.

Materials and methods: We investigated the clinical significance of LOC441461 expression in lung cancer using bioinformatics analyses. To explore the biological function of LOC441461, we performed siRNA-mediated knockdown in lung cancer cells and evaluated its effects on cell proliferation, colony formation, apoptosis, and cell cycle progression.

Results: LOC441461 was found to be significantly overexpressed in lung adenocarcinoma (LUAD), and LOC441461 overexpression was significantly associated with poor prognosis in patients with LUAD. LOC441461 knockdown significantly inhibited cell growth and induced a modest but statistically significant increase in apoptosis in lung cancer cells. According to a cell cycle analysis, LOC441461 knockdown induced G0/G1 arrest in A549 cells; increased p21 and p27 expression; and reduced the levels of CDK4 and the cyclins A2, B1, and D1, similar to p53-dependent regulation. By contrast, H1299 cells exhibited G2/M accumulation with no change in p21 and p27 levels, suggesting a p53-independent mechanism.

Conclusion: Our findings indicate that high LOC441461 expression is correlated with worse prognosis in LUAD. These results support the potential of LOC441461 as a novel therapeutic and prognostic target in LUAD.

目的:LOC441461(一种长链非编码RNA)在不同癌症类型中的作用不同,其在肺癌中的作用尚不清楚。材料与方法:应用生物信息学分析方法探讨LOC441461在肺癌组织中表达的临床意义。为了探索LOC441461的生物学功能,我们在肺癌细胞中进行了sirna介导的敲低,并评估了其对细胞增殖、集落形成、凋亡和细胞周期进展的影响。结果:发现LOC441461在肺腺癌(LUAD)中显著过表达,且LOC441461过表达与LUAD患者预后不良显著相关。LOC441461敲低显著抑制细胞生长,诱导肺癌细胞凋亡适度增加,但有统计学意义。细胞周期分析显示,LOC441461敲低诱导A549细胞G0/G1阻滞;p21、p27表达增加;并降低CDK4和细胞周期蛋白A2, B1和D1的水平,类似于p53依赖性调节。相比之下,H1299细胞表现出G2/M积累,p21和p27水平未发生变化,提示不依赖于p53的机制。结论:LOC441461高表达与LUAD患者预后不良相关。这些结果支持LOC441461作为LUAD新的治疗和预后靶点的潜力。
{"title":"Long noncoding RNA LOC441461 drives cancer growth and is associated with poor clinical outcomes.","authors":"Ching-Feng Cheng, Ya-Ting Tu, Yi-Ru Chen, Ming-Cheng Lee, Hui-Chen Ku, Kuo-Wang Tsai","doi":"10.4103/tcmj.TCMJ-D-25-00032","DOIUrl":"https://doi.org/10.4103/tcmj.TCMJ-D-25-00032","url":null,"abstract":"<p><strong>Objectives: </strong>The role of LOC441461, a long noncoding RNA, differs in different cancer types, and its role in lung cancer remains unclear.</p><p><strong>Materials and methods: </strong>We investigated the clinical significance of LOC441461 expression in lung cancer using bioinformatics analyses. To explore the biological function of LOC441461, we performed siRNA-mediated knockdown in lung cancer cells and evaluated its effects on cell proliferation, colony formation, apoptosis, and cell cycle progression.</p><p><strong>Results: </strong>LOC441461 was found to be significantly overexpressed in lung adenocarcinoma (LUAD), and LOC441461 overexpression was significantly associated with poor prognosis in patients with LUAD. LOC441461 knockdown significantly inhibited cell growth and induced a modest but statistically significant increase in apoptosis in lung cancer cells. According to a cell cycle analysis, LOC441461 knockdown induced G0/G1 arrest in A549 cells; increased p21 and p27 expression; and reduced the levels of CDK4 and the cyclins A2, B1, and D1, similar to p53-dependent regulation. By contrast, H1299 cells exhibited G2/M accumulation with no change in p21 and p27 levels<b>,</b> suggesting a p53-independent mechanism.</p><p><strong>Conclusion: </strong>Our findings indicate that high LOC441461 expression is correlated with worse prognosis in LUAD. These results support the potential of LOC441461 as a novel therapeutic and prognostic target in LUAD.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"75-82"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885466/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaginal septum in women: A review of diagnosis, management, and obstetric outcomes.
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 eCollection Date: 2026-01-01 DOI: 10.4103/tcmj.TCMJ-D-25-00041
Ya-Chu Wu, Pei-Chen Li, Dah-Ching Ding

Congenital anomalies of the female genital tract, such as vaginal septa, arise from disruptions in Müllerian ducts and urogenital sinus development. Vaginal septa, including longitudinal and transverse types, are rare and often remain undiagnosed due to asymptomatic presentation. However, they can lead to significant complications such as dyspareunia, infertility, and obstructed labor. This narrative review aims to provide a detailed overview of the clinical presentation, diagnosis, and management of vaginal septum, with a particular focus on the challenges encountered during pregnancy and labor. A systematic search of PubMed, Web of Science, Scopus, and Embase identified 34 relevant articles, including 16 case reports detailing labor outcomes in women with vaginal septum. The review highlights that timely diagnosis through pelvic examination and imaging, such as magnetic resonance imaging or ultrasound, can prevent labor complications. Management options range from conservative observation in asymptomatic cases to surgical resection, which can be performed intrapartum or before delivery to facilitate vaginal birth. The presence of associated anomalies, including uterine malformations and renal agenesis, underscores the need for thorough evaluation. Postoperative outcomes are generally favorable, though careful surgical planning is essential to avoid complications such as restenosis or infection. Clinicians should remain highly vigilant for women with unexplained infertility, menstrual abnormalities, or labor obstruction. Early identification and individualized management of vaginal septum can optimize obstetric outcomes and preserve reproductive function. Future research should aim to improve early detection methods, refine surgical techniques, and investigate the genetic and embryological basis of these rare anomalies.

女性生殖道的先天性异常,如阴道间隔,是由勒氏管和泌尿生殖道窦发育的中断引起的。阴道间隔,包括纵向和横向型,是罕见的,往往仍未确诊,由于无症状的表现。然而,它们会导致严重的并发症,如性交困难、不孕症和难产。这篇叙述性综述的目的是提供阴道间隔的临床表现,诊断和管理的详细概述,特别侧重于怀孕和分娩期间遇到的挑战。通过对PubMed、Web of Science、Scopus和Embase的系统搜索,我们发现了34篇相关文章,其中包括16篇详细介绍阴道间隔妇女分娩结果的病例报告。回顾强调,及时诊断盆腔检查和影像学,如磁共振成像或超声,可以预防分娩并发症。治疗方案包括对无症状病例的保守观察到手术切除,手术切除可在产时或分娩前进行,以促进阴道分娩。存在相关的异常,包括子宫畸形和肾脏发育不全,强调需要进行彻底的评估。术后结果通常是良好的,尽管仔细的手术计划是必要的,以避免并发症,如再狭窄或感染。临床医生应对不明原因不孕、月经异常或分娩梗阻的妇女保持高度警惕。阴道间隔的早期识别和个体化治疗可以优化产科结局,保护生殖功能。未来的研究应致力于改进早期检测方法,改进手术技术,并研究这些罕见异常的遗传和胚胎学基础。
{"title":"Vaginal septum in women: A review of diagnosis, management, and obstetric outcomes.","authors":"Ya-Chu Wu, Pei-Chen Li, Dah-Ching Ding","doi":"10.4103/tcmj.TCMJ-D-25-00041","DOIUrl":"https://doi.org/10.4103/tcmj.TCMJ-D-25-00041","url":null,"abstract":"<p><p>Congenital anomalies of the female genital tract, such as vaginal septa, arise from disruptions in Müllerian ducts and urogenital sinus development. Vaginal septa, including longitudinal and transverse types, are rare and often remain undiagnosed due to asymptomatic presentation. However, they can lead to significant complications such as dyspareunia, infertility, and obstructed labor. This narrative review aims to provide a detailed overview of the clinical presentation, diagnosis, and management of vaginal septum, with a particular focus on the challenges encountered during pregnancy and labor. A systematic search of PubMed, Web of Science, Scopus, and Embase identified 34 relevant articles, including 16 case reports detailing labor outcomes in women with vaginal septum. The review highlights that timely diagnosis through pelvic examination and imaging, such as magnetic resonance imaging or ultrasound, can prevent labor complications. Management options range from conservative observation in asymptomatic cases to surgical resection, which can be performed intrapartum or before delivery to facilitate vaginal birth. The presence of associated anomalies, including uterine malformations and renal agenesis, underscores the need for thorough evaluation. Postoperative outcomes are generally favorable, though careful surgical planning is essential to avoid complications such as restenosis or infection. Clinicians should remain highly vigilant for women with unexplained infertility, menstrual abnormalities, or labor obstruction. Early identification and individualized management of vaginal septum can optimize obstetric outcomes and preserve reproductive function. Future research should aim to improve early detection methods, refine surgical techniques, and investigate the genetic and embryological basis of these rare anomalies.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"40-47"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of an enhanced sensitivity method for lateral flow immunoassays: An overview of strategies.
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 eCollection Date: 2026-01-01 DOI: 10.4103/tcmj.TCMJ-D-25-00061
Chung-An Chen, Chi-Hung Liu, Natalie Yi-Ju Ho, Sheng Liu, Tsung-Ting Tsai

Lateral flow immunoassay (LFIA) is a widely recognized point-of-care diagnostic platform for detecting various analytes. It must meet the criteria of REASSURED, but poor sensitivity and lack of precision in test results remain the main bottlenecks of LFIA. Therefore, signal enhancement methods, such as devices, nanoprobes, or detection modes, can improve this platform. In this paper, many representative studies from the past decade on LFIA sensing platforms will be discussed in detail.

侧流免疫分析法(LFIA)是一种广泛认可的检测各种分析物的即时诊断平台。它必须满足放心的标准,但灵敏度差和测试结果精度不足仍然是LFIA的主要瓶颈。因此,信号增强方法,如器件、纳米探针或检测模式,可以改善这个平台。本文将详细讨论近十年来在LFIA传感平台上的许多有代表性的研究。
{"title":"Development of an enhanced sensitivity method for lateral flow immunoassays: An overview of strategies.","authors":"Chung-An Chen, Chi-Hung Liu, Natalie Yi-Ju Ho, Sheng Liu, Tsung-Ting Tsai","doi":"10.4103/tcmj.TCMJ-D-25-00061","DOIUrl":"https://doi.org/10.4103/tcmj.TCMJ-D-25-00061","url":null,"abstract":"<p><p>Lateral flow immunoassay (LFIA) is a widely recognized point-of-care diagnostic platform for detecting various analytes. It must meet the criteria of REASSURED, but poor sensitivity and lack of precision in test results remain the main bottlenecks of LFIA. Therefore, signal enhancement methods, such as devices, nanoprobes, or detection modes, can improve this platform. In this paper, many representative studies from the past decade on LFIA sensing platforms will be discussed in detail.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"11-20"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885459/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of functional ability in autism spectrum disorder: A scoping review.
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 eCollection Date: 2026-01-01 DOI: 10.4103/tcmj.tcmj_319_24
Purboyo Solek, Eka Nurfitri, Taufan Prasetya, Anggia Farrah Rizqiamuti, Indra Sahril, Burhan, Uni Gamayani, Kusnandi Rusmil, Irvan Afriandi, Lukman Ade Chandra, Kevin Gunawan

Autism spectrum disorder (ASD) is a group of diverse neurodevelopmental conditions characterized by deficits in social communication and interaction, as well as confined and repetitive patterns of behaviors, interests, or activities. Currently, there are no standardized techniques for predicting functional ability in children with ASD, which can lead to undetected clinical impairments and delayed targeted treatments. To address this issue, a scoping review was conducted following the preferred reporting items for systematic reviews and meta-analyses criteria. Twelve articles met the inclusion criteria for this review. This study summarized the potential tools and parameters that may benefit in predicting abilities used in the daily lives of children with ASD. The collected tools varied widely, including clinical questionnaires, physical symptoms, laboratory tests, and imaging studies. These tools provided descriptions of various functional abilities that are altered in ASD, offering insights into the diverse manifestations of the disorder and potential approaches for assessment and intervention.

自闭症谱系障碍(ASD)是一组不同的神经发育状况,其特征是社会沟通和互动的缺陷,以及限制和重复的行为、兴趣或活动模式。目前,还没有标准化的技术来预测自闭症儿童的功能能力,这可能导致未被发现的临床损伤和延迟靶向治疗。为了解决这个问题,根据系统评价和荟萃分析标准的首选报告项目进行了范围审查。12篇文章符合本综述的纳入标准。本研究总结了可能有利于预测自闭症儿童日常生活能力的潜在工具和参数。收集的工具多种多样,包括临床问卷、身体症状、实验室检查和影像学研究。这些工具提供了ASD中各种功能能力改变的描述,为该疾病的各种表现以及评估和干预的潜在方法提供了见解。
{"title":"Predictors of functional ability in autism spectrum disorder: A scoping review.","authors":"Purboyo Solek, Eka Nurfitri, Taufan Prasetya, Anggia Farrah Rizqiamuti, Indra Sahril, Burhan, Uni Gamayani, Kusnandi Rusmil, Irvan Afriandi, Lukman Ade Chandra, Kevin Gunawan","doi":"10.4103/tcmj.tcmj_319_24","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_319_24","url":null,"abstract":"<p><p>Autism spectrum disorder (ASD) is a group of diverse neurodevelopmental conditions characterized by deficits in social communication and interaction, as well as confined and repetitive patterns of behaviors, interests, or activities. Currently, there are no standardized techniques for predicting functional ability in children with ASD, which can lead to undetected clinical impairments and delayed targeted treatments. To address this issue, a scoping review was conducted following the preferred reporting items for systematic reviews and meta-analyses criteria. Twelve articles met the inclusion criteria for this review. This study summarized the potential tools and parameters that may benefit in predicting abilities used in the daily lives of children with ASD. The collected tools varied widely, including clinical questionnaires, physical symptoms, laboratory tests, and imaging studies. These tools provided descriptions of various functional abilities that are altered in ASD, offering insights into the diverse manifestations of the disorder and potential approaches for assessment and intervention.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"48-58"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885451/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing self-care implementation and reducing marker detachment rates in cancer radiotherapy patients through diverse nursing care strategies.
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-13 eCollection Date: 2026-01-01 DOI: 10.4103/tcmj.tcmj_121_25
Huei-Fang Yang, Hsueh-Ya Tsai, Ying-Hsiang Chou, Yu-Chen Hsieh, Shao-Ti Li, Hsiao-Ju Huang, Ya-Fang Ke, Pei-Fang Tsai, Hsiu-Man Chan, Yueh-Chun Lee
<p><strong>Objectives: </strong>During radiation therapy, clear and stable body-surface markers are essential for accurate patient positioning. Peer benchmarking across four Taiwanese tertiary centers (January 2023-Mar 2024) revealed marker detachment rates of 0.8%-10.7%, whereas our in-house audit documented 15%, underscoring a significant quality gap (unpublished institutional quality assurance data). Marker detachment or fading commonly occurs due to daily activities, hygiene routines, and patient-specific factors, adversely affecting treatment accuracy, prolonging treatment duration, and increasing patient anxiety and medical costs. This study aimed to reduce the rate of marker detachment in radiotherapy patients from the previous level of approximately 15% to below 5%, thereby decreasing repositioning time, treatment delays, patient anxiety, family inconvenience, and hospital resource expenditure.</p><p><strong>Materials and methods: </strong>This was a single-center pre-post comparative study conducted from January to June 2023. Two hundred cancer patients undergoing radiation therapy participated in this study. Patients were classified using an in-house-developed red-green light marking system based on body mass index (BMI >25 or ≤25), educational level (high school or below and above high school), and presence of a specific caregiver. Patients with higher risk (BMI >25, education level ≤ high school, and no specific caregiver) received weekly education sessions emphasizing marker maintenance, whereas lower-risk patients received sessions at the beginning, middle, and near the end of treatment. Interventions included personalized educational pamphlets, hypoallergenic adhesive patches, standardized marker pen replacements, and systematic tracking using the MOSAIQ® Radiation Oncology Management System (Elekta AB, Sweden). Data on marker detachment rates, repositioning times, and patient anxiety (Beck Anxiety Inventory) were collected before and after implementation. Statistical analyses, including paired <i>t</i>-tests, were conducted to assess the significance of observed changes.</p><p><strong>Results: </strong>After the implementation of interventions, marker repositioning incidents significantly decreased from 82 instances (average 102.5 min/month) to 7 instances (average 23.4 min/month) (<i>P</i> < 0.001). The marker detachment rate was effectively reduced from approximately 15% to 3.5%, achieving the targeted goal. In addition, patient anxiety scores significantly decreased from an average of 5 points to 3 points (<i>P</i> < 0.001), reflecting clinically meaningful improvement.</p><p><strong>Conclusion: </strong>The implementation of a structured nursing intervention program, featuring a red-green light marking system, personalized education, and systematic management, effectively decreased marker detachment rates, repositioning times, and patient anxiety. These improvements highlight the feasibility and effectiveness of integrating su
目的:在放射治疗过程中,清晰稳定的体表标记对于患者的准确定位至关重要。在台湾四所高等教育中心(2023年1月至2024年3月)的同行基准测试显示,市场脱离率为0.8%-10.7%,而我们的内部审计记录为15%,强调了显著的质量差距(未公布的机构质量保证数据)。由于日常活动、卫生习惯和患者自身因素等原因,常发生标记物脱离或褪色,影响治疗准确性,延长治疗时间,增加患者焦虑和医疗费用。本研究旨在将放疗患者的标记物脱离率从之前的约15%降低到5%以下,从而减少重新定位时间、治疗延误、患者焦虑、家庭不便和医院资源消耗。材料和方法:本研究为单中心前后比较研究,于2023年1月至6月进行。200名接受放射治疗的癌症患者参与了这项研究。患者根据身体质量指数(BMI bbbb25或≤25)、教育水平(高中或高中以下及高中以上)和是否有特定护理人员对患者进行分类。高危患者(BMI指数为bbb25,受教育程度≤高中,无特定照顾者)每周接受强调标志物维持的教育,而低危患者在治疗开始、中期和接近结束时接受教育。干预措施包括个性化教育小册子、低致敏贴、标准化标记笔更换,以及使用MOSAIQ®放射肿瘤学管理系统(Elekta AB,瑞典)进行系统跟踪。在实施前后收集标记物脱离率、重新定位时间和患者焦虑(贝克焦虑量表)的数据。统计分析,包括配对t检验,评估观察到的变化的显著性。结果:干预实施后,标志物重新定位事件由82例(平均102.5 min/月)显著减少至7例(平均23.4 min/月)(P < 0.001)。标记物脱离率从大约15%有效降低到3.5%,达到了预期目标。此外,患者焦虑评分从平均5分显著下降到3分(P < 0.001),反映出有临床意义的改善。结论:实施以红绿灯标记制度、个性化教育、系统化管理为特征的结构化护理干预方案,可有效降低标记脱离率、重新定位次数和患者焦虑。这些改进突出了将这些干预措施整合到常规放射肿瘤学实践中的可行性和有效性,最终提高了治疗准确性、患者舒适度和资源效率。
{"title":"Enhancing self-care implementation and reducing marker detachment rates in cancer radiotherapy patients through diverse nursing care strategies.","authors":"Huei-Fang Yang, Hsueh-Ya Tsai, Ying-Hsiang Chou, Yu-Chen Hsieh, Shao-Ti Li, Hsiao-Ju Huang, Ya-Fang Ke, Pei-Fang Tsai, Hsiu-Man Chan, Yueh-Chun Lee","doi":"10.4103/tcmj.tcmj_121_25","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_121_25","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;During radiation therapy, clear and stable body-surface markers are essential for accurate patient positioning. Peer benchmarking across four Taiwanese tertiary centers (January 2023-Mar 2024) revealed marker detachment rates of 0.8%-10.7%, whereas our in-house audit documented 15%, underscoring a significant quality gap (unpublished institutional quality assurance data). Marker detachment or fading commonly occurs due to daily activities, hygiene routines, and patient-specific factors, adversely affecting treatment accuracy, prolonging treatment duration, and increasing patient anxiety and medical costs. This study aimed to reduce the rate of marker detachment in radiotherapy patients from the previous level of approximately 15% to below 5%, thereby decreasing repositioning time, treatment delays, patient anxiety, family inconvenience, and hospital resource expenditure.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;This was a single-center pre-post comparative study conducted from January to June 2023. Two hundred cancer patients undergoing radiation therapy participated in this study. Patients were classified using an in-house-developed red-green light marking system based on body mass index (BMI &gt;25 or ≤25), educational level (high school or below and above high school), and presence of a specific caregiver. Patients with higher risk (BMI &gt;25, education level ≤ high school, and no specific caregiver) received weekly education sessions emphasizing marker maintenance, whereas lower-risk patients received sessions at the beginning, middle, and near the end of treatment. Interventions included personalized educational pamphlets, hypoallergenic adhesive patches, standardized marker pen replacements, and systematic tracking using the MOSAIQ® Radiation Oncology Management System (Elekta AB, Sweden). Data on marker detachment rates, repositioning times, and patient anxiety (Beck Anxiety Inventory) were collected before and after implementation. Statistical analyses, including paired &lt;i&gt;t&lt;/i&gt;-tests, were conducted to assess the significance of observed changes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;After the implementation of interventions, marker repositioning incidents significantly decreased from 82 instances (average 102.5 min/month) to 7 instances (average 23.4 min/month) (&lt;i&gt;P&lt;/i&gt; &lt; 0.001). The marker detachment rate was effectively reduced from approximately 15% to 3.5%, achieving the targeted goal. In addition, patient anxiety scores significantly decreased from an average of 5 points to 3 points (&lt;i&gt;P&lt;/i&gt; &lt; 0.001), reflecting clinically meaningful improvement.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The implementation of a structured nursing intervention program, featuring a red-green light marking system, personalized education, and systematic management, effectively decreased marker detachment rates, repositioning times, and patient anxiety. These improvements highlight the feasibility and effectiveness of integrating su","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"117-122"},"PeriodicalIF":1.6,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Judkins left catheter size selection during right trans-radial coronary angiography using preprocedural coronary computed tomography angiography.
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-07 eCollection Date: 2026-01-01 DOI: 10.4103/tcmj.tcmj_56_25
Abdulameer Jasim Jawad Al-Gburi

Objectives: Proper catheter selection during right trans-radial coronary angiography reduces procedure duration, costs, and vascular complications. The correlation between aorta morphological parameters assessed through computed tomography (CT) and requirement for larger catheter size was investigated in this study.

Materials and methods: This observational study includes 206 patients who underwent right trans-radial coronary angiography and had already undergone coronary CT angiography at a recognized center from April 2023 to January 2025. Patients who completed angiography using a Judkins left (JL) 3.5 (Group 1) catheter were compared with patients who required catheter exchange with a JL 4 or larger (Group 2). Both groups had their CT images analyzed for four specific aortic morphological variables.

Results: A total of 167 patients formed Group 1, whereas 39 patients formed Group 2. The significant differences were detected in the maximal area and length of the ascending aorta among the four aortic CT variables. In multivariable logistic regression model, the strongest association with the need for JL4 or more catheter (Group 2) was found with the maximal area of the ascending aorta (odds ratio [OR] 31.82 [(95% confidence interval [CI]) 1.21-831.18], P < 0.001) followed by length of the ascending aorta (OR 29.97 [(95% CI) 1.06-845.08], P < 0.001). An ascending aorta maximal area cutoff value was 12.25 cm2 (SN 94.9%, SP 95.2%) with the derived diameter of 3.94 cm.

Conclusion: Maximum area (with derived diameter) and ascending aortic length were the good predictors for suitable catheter selection during right trans-radial invasive coronary angiography.

目的:正确的导管选择在右经桡动脉冠状动脉造影减少手术时间,费用和血管并发症。本研究探讨了通过计算机断层扫描(CT)评估的主动脉形态参数与需要更大导管尺寸之间的相关性。材料和方法:本观察性研究包括2023年4月至2025年1月在某知名中心行右经桡动脉冠状动脉造影并已行冠状动脉CT血管造影的206例患者。使用Judkins左(JL) 3.5导管完成血管造影的患者(第1组)与使用JL 4或更大导管更换导管的患者(第2组)进行比较。两组的CT图像分析了四种特定的主动脉形态变量。结果:1组167例,2组39例。升主动脉的最大面积和长度在4个主动脉CT变量之间存在显著差异。在多变量logistic回归模型中,与JL4或以上导管需要量相关性最强的是升主动脉最大面积(比值比[or] 31.82[(95%可信区间[CI]) 1.21-831.18], P < 0.001),其次是升主动脉长度(比值比[or] 29.97 [(95% CI) 1.06-845.08], P < 0.001)。升主动脉最大截面积12.25 cm2 (SN 94.9%, SP 95.2%),衍生直径3.94 cm。结论:经桡动脉有创冠状动脉造影时,最大面积(带衍生直径)和升主动脉长度是选择合适导管的良好预测指标。
{"title":"Judkins left catheter size selection during right trans-radial coronary angiography using preprocedural coronary computed tomography angiography.","authors":"Abdulameer Jasim Jawad Al-Gburi","doi":"10.4103/tcmj.tcmj_56_25","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_56_25","url":null,"abstract":"<p><strong>Objectives: </strong>Proper catheter selection during right trans-radial coronary angiography reduces procedure duration, costs, and vascular complications. The correlation between aorta morphological parameters assessed through computed tomography (CT) and requirement for larger catheter size was investigated in this study.</p><p><strong>Materials and methods: </strong>This observational study includes 206 patients who underwent right trans-radial coronary angiography and had already undergone coronary CT angiography at a recognized center from April 2023 to January 2025. Patients who completed angiography using a Judkins left (JL) 3.5 (Group 1) catheter were compared with patients who required catheter exchange with a JL 4 or larger (Group 2). Both groups had their CT images analyzed for four specific aortic morphological variables.</p><p><strong>Results: </strong>A total of 167 patients formed Group 1, whereas 39 patients formed Group 2. The significant differences were detected in the maximal area and length of the ascending aorta among the four aortic CT variables. In multivariable logistic regression model, the strongest association with the need for JL4 or more catheter (Group 2) was found with the maximal area of the ascending aorta (odds ratio [OR] 31.82 [(95% confidence interval [CI]) 1.21-831.18], <i>P</i> < 0.001) followed by length of the ascending aorta (OR 29.97 [(95% CI) 1.06-845.08], <i>P</i> < 0.001). An ascending aorta maximal area cutoff value was 12.25 cm<sup>2</sup> (SN 94.9%, SP 95.2%) with the derived diameter of 3.94 cm.</p><p><strong>Conclusion: </strong>Maximum area (with derived diameter) and ascending aortic length were the good predictors for suitable catheter selection during right trans-radial invasive coronary angiography.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"104-109"},"PeriodicalIF":1.6,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microglial activation and lysosomal dysfunction in hemorrhagic stroke.
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-11-07 eCollection Date: 2026-01-01 DOI: 10.4103/tcmj.tcmj_213_25
Chien-Hui Lee, Cheng-Yoong Pang, Mei-Jen Wang, Wei-Fen Hu, Hsin-Yi Huang, Sheng-Tzung Tsai, Hock-Kean Liew

Hemorrhagic stroke, mainly caused by intracerebral hemorrhage (ICH), is a severe neurological condition with high mortality and lasting disability. ICH involves bleeding into the brain parenchyma, hematoma formation, and subsequent edema and tissue damage, triggering inflammatory and degenerative responses that worsen secondary brain injury (SBI). Microglia, the brain's resident immune cells, are key mediators in this process. Their ability to sense, engulf, and clear hematoma-derived debris is essential for controlling neuroinflammation and promoting tissue repair. Central to microglial phagocytosis is lysosomal function. Lysosomes contain hydrolases - proteases, glycosidases, lipases, and nucleases - that degrade proteins, lipids, carbohydrates, and nucleic acids. This coordinated degradation ensures effective recycling of phagocytosed materials and clearance of cellular debris after hemorrhage. However, lysosomal dysfunction impairs microglial clearance capacity, leading to persistent inflammation, aggravated neuronal damage, and poor neurological recovery after ICH. This review focuses on the interplay between microglial activation, lysosomal function, and phagocytosis in hemorrhagic stroke. We examine how lysosomal impairment hinders hematoma resolution, propagates SBI, and delays functional recovery. In addition, we highlight emerging therapeutic strategies targeting the microglia-lysosome axis, such as enhancing lysosomal biogenesis and enzyme activity, as promising approaches to boost hematoma clearance and improve outcomes. Understanding and modulating microglial lysosomal function offers novel therapeutic avenues for ICH management, aiming to mitigate secondary injury and support neurological recovery.

出血性中风是一种严重的神经系统疾病,主要由脑出血引起,死亡率高,致残性强。脑出血包括脑实质出血、血肿形成以及随后的水肿和组织损伤,引发炎症和退行性反应,加重继发性脑损伤(SBI)。小胶质细胞,大脑的常驻免疫细胞,是这个过程中的关键媒介。它们感知、吞噬和清除血肿碎片的能力对于控制神经炎症和促进组织修复至关重要。小胶质细胞吞噬的核心是溶酶体功能。溶酶体含有水解酶——蛋白酶、糖苷酶、脂肪酶和核酸酶——它们能降解蛋白质、脂质、碳水化合物和核酸。这种协调降解确保了出血后被吞噬物质的有效回收和细胞碎片的清除。然而,溶酶体功能障碍损害小胶质细胞清除能力,导致持续炎症,加重神经元损伤,脑出血后神经系统恢复不良。本文综述了出血性卒中中小胶质细胞活化、溶酶体功能和吞噬之间的相互作用。我们研究溶酶体损伤如何阻碍血肿消退,传播SBI,并延迟功能恢复。此外,我们强调了针对小胶质细胞-溶酶体轴的新兴治疗策略,如增强溶酶体的生物发生和酶活性,作为促进血肿清除和改善预后的有希望的方法。了解和调节小胶质溶酶体功能为脑出血治疗提供了新的治疗途径,旨在减轻继发性损伤和支持神经系统恢复。
{"title":"Microglial activation and lysosomal dysfunction in hemorrhagic stroke.","authors":"Chien-Hui Lee, Cheng-Yoong Pang, Mei-Jen Wang, Wei-Fen Hu, Hsin-Yi Huang, Sheng-Tzung Tsai, Hock-Kean Liew","doi":"10.4103/tcmj.tcmj_213_25","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_213_25","url":null,"abstract":"<p><p>Hemorrhagic stroke, mainly caused by intracerebral hemorrhage (ICH), is a severe neurological condition with high mortality and lasting disability. ICH involves bleeding into the brain parenchyma, hematoma formation, and subsequent edema and tissue damage, triggering inflammatory and degenerative responses that worsen secondary brain injury (SBI). Microglia, the brain's resident immune cells, are key mediators in this process. Their ability to sense, engulf, and clear hematoma-derived debris is essential for controlling neuroinflammation and promoting tissue repair. Central to microglial phagocytosis is lysosomal function. Lysosomes contain hydrolases - proteases, glycosidases, lipases, and nucleases - that degrade proteins, lipids, carbohydrates, and nucleic acids. This coordinated degradation ensures effective recycling of phagocytosed materials and clearance of cellular debris after hemorrhage. However, lysosomal dysfunction impairs microglial clearance capacity, leading to persistent inflammation, aggravated neuronal damage, and poor neurological recovery after ICH. This review focuses on the interplay between microglial activation, lysosomal function, and phagocytosis in hemorrhagic stroke. We examine how lysosomal impairment hinders hematoma resolution, propagates SBI, and delays functional recovery. In addition, we highlight emerging therapeutic strategies targeting the microglia-lysosome axis, such as enhancing lysosomal biogenesis and enzyme activity, as promising approaches to boost hematoma clearance and improve outcomes. Understanding and modulating microglial lysosomal function offers novel therapeutic avenues for ICH management, aiming to mitigate secondary injury and support neurological recovery.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"1-10"},"PeriodicalIF":1.6,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting large middle molecules: Clinical implications of expanded hemodialysis in hemodialysis care.
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-14 eCollection Date: 2026-01-01 DOI: 10.4103/tcmj.tcmj_192_25
Chiu-Huang Kuo, Yu-Li Lin, Chi-Chong Tang, Bang-Gee Hsu

End-stage kidney disease (ESKD) presents a major clinical burden, with maintenance hemodialysis (HD) patients facing high cardiovascular mortality and impaired quality of life (QoL). Despite advances from low-flux to high-flux HD and the introduction of hemodiafiltration (HDF), clearance of large middle molecules (LMMs >25 kDa) remains inadequate. These molecules contribute to inflammation, oxidative stress, atherogenesis, and mineral-bone disorders, all of which worsen patient outcomes. Expanded hemodialysis (HDx), utilizing medium cutoff membranes, represents a novel approach that combines diffusion and enhanced internal convection to improve LMMs removal, without the need for substitution fluid. This review explores the limitations of conventional HD, the pathological roles of LMMs, and the evolution of dialysis strategies aimed at enhancing solute clearance. Evidence from observational studies, randomized trials, and meta-analyses shows that HDx improves the removal of inflammatory LMMs, reduces hospitalization burden, preserves residual kidney function, and enhances patient-reported outcomes such as recovery time and symptom relief. Furthermore, HDx offers a practical and cost-effective alternative to online HDF (OL-HDF), particularly in the resource-limited settings, achieving comparable efficacy with shorter sessions and lower blood flow requirements. By addressing the key shortcomings of traditional HD and approaching the solute clearance profile of the native kidney, HDx offers a promising advancement in the care of ESKD patients.

终末期肾脏疾病(ESKD)是一个主要的临床负担,维持性血液透析(HD)患者面临着高心血管死亡率和生活质量受损(QoL)。尽管HD从低通量发展到高通量,并引入了血液滤过(HDF),但大分子(lmm)的清除率仍然不足。这些分子会导致炎症、氧化应激、动脉粥样硬化和矿物质骨骼紊乱,所有这些都会使患者的预后恶化。扩展血液透析(HDx),利用介质切断膜,代表了一种新的方法,结合扩散和增强内部对流,以提高lmm的去除,而不需要替代流体。这篇综述探讨了传统HD的局限性,lmm的病理作用,以及旨在提高溶质清除的透析策略的发展。来自观察性研究、随机试验和荟萃分析的证据表明,HDx可改善炎性lmm的清除,减轻住院负担,保留残余肾功能,并提高患者报告的结果,如恢复时间和症状缓解。此外,HDx为在线HDF (OL-HDF)提供了一种实用且具有成本效益的替代方案,特别是在资源有限的情况下,以更短的疗程和更低的血流量要求达到相同的效果。通过解决传统HD的主要缺点和接近天然肾脏的溶质清除特征,HDx在ESKD患者的护理中提供了一个有希望的进步。
{"title":"Targeting large middle molecules: Clinical implications of expanded hemodialysis in hemodialysis care.","authors":"Chiu-Huang Kuo, Yu-Li Lin, Chi-Chong Tang, Bang-Gee Hsu","doi":"10.4103/tcmj.tcmj_192_25","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_192_25","url":null,"abstract":"<p><p>End-stage kidney disease (ESKD) presents a major clinical burden, with maintenance hemodialysis (HD) patients facing high cardiovascular mortality and impaired quality of life (QoL). Despite advances from low-flux to high-flux HD and the introduction of hemodiafiltration (HDF), clearance of large middle molecules (LMMs >25 kDa) remains inadequate. These molecules contribute to inflammation, oxidative stress, atherogenesis, and mineral-bone disorders, all of which worsen patient outcomes. Expanded hemodialysis (HDx), utilizing medium cutoff membranes, represents a novel approach that combines diffusion and enhanced internal convection to improve LMMs removal, without the need for substitution fluid. This review explores the limitations of conventional HD, the pathological roles of LMMs, and the evolution of dialysis strategies aimed at enhancing solute clearance. Evidence from observational studies, randomized trials, and meta-analyses shows that HDx improves the removal of inflammatory LMMs, reduces hospitalization burden, preserves residual kidney function, and enhances patient-reported outcomes such as recovery time and symptom relief. Furthermore, HDx offers a practical and cost-effective alternative to online HDF (OL-HDF), particularly in the resource-limited settings, achieving comparable efficacy with shorter sessions and lower blood flow requirements. By addressing the key shortcomings of traditional HD and approaching the solute clearance profile of the native kidney, HDx offers a promising advancement in the care of ESKD patients.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"31-39"},"PeriodicalIF":1.6,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stress, inflammation, and resilience among patients with oral squamous cell carcinoma undergoing multimodal therapy: Current knowledge and future directions.
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-10-14 eCollection Date: 2026-01-01 DOI: 10.4103/tcmj.tcmj_208_25
Tai-Chu Peng, Chun-Hou Huang, Yu-Fu Chou, Peir-Rong Chen

Oral squamous cell carcinoma represents a significant public health challenge in Asia, where multimodal therapies, while extending survival, impose substantial biologic and psychosocial stress. Sustained activation of the sympathetic-adrenal-medullary axis and dysregulation of the hypothalamic-pituitary-adrenal axis increase catecholamines, cortisol, interleukin-6, and C-reactive protein, accelerating tumor progression, impairing treatment tolerance, and increasing cardiovascular risk. Betel quid chewing, prevalent in the region, exacerbates inflammation and contributes to cardiovascular comorbidities. Resilience, defined as the ability to restore physiologic and emotional homeostasis, modulates these pathways, with higher resilience linked to improved recovery, quality of life, and survival. Current evidence supports interventions including structured psychoeducation, cognitive-behavioral therapy, and peer mentoring to reduce anxiety and enhance treatment adherence. Smoking and betel quid cessation, alongside cardiometabolic optimization, mitigate inflammatory burden. Nonopioid strategies, including acupuncture, transcutaneous vagus nerve stimulation, and mindfulness, recalibrate neuro-immune signaling while minimizing opioid reliance. Enhanced recovery surgical protocols and omega-3 supplementation attenuate inflammatory responses and preserve lean mass. Emerging biomarkers such as heart rate variability and neutrophil-lymphocyte ratio show promise for real-time stress and inflammation monitoring. Digital health technologies and telerehabilitation extend intervention benefits postdischarge. Future research should focus on validating predictive biomarkers, developing resilience-stratified trials, integrating cardio-oncology surveillance, and implementing precision supportive care models that incorporate stress, inflammation, and resilience metrics to optimize oncologic and cardiovascular outcomes in this high-risk population.

口腔鳞状细胞癌在亚洲是一个重大的公共卫生挑战,在那里,多模式治疗虽然延长了生存期,但造成了巨大的生物和社会心理压力。交感神经-肾上腺-髓质轴的持续激活和下丘脑-垂体-肾上腺轴的失调会增加儿茶酚胺、皮质醇、白细胞介素-6和c反应蛋白,加速肿瘤进展,损害治疗耐受性,增加心血管风险。在该地区流行的嚼槟榔液会加剧炎症并导致心血管合并症。弹性,定义为恢复生理和情绪平衡的能力,调节这些途径,较高的弹性与改善的恢复,生活质量和生存有关。目前的证据支持包括结构化心理教育、认知行为疗法和同伴指导在内的干预措施,以减少焦虑和提高治疗依从性。吸烟和戒烟槟榔,与心脏代谢优化,减轻炎症负担。非阿片类药物策略,包括针灸、经皮迷走神经刺激和正念,在减少阿片类药物依赖的同时重新校准神经免疫信号。增强恢复手术方案和omega-3补充减轻炎症反应和保持瘦质量。新兴的生物标志物,如心率变异性和中性粒细胞-淋巴细胞比率,显示出实时压力和炎症监测的前景。数字卫生技术和远程康复扩大了出院后的干预效益。未来的研究应侧重于验证预测性生物标志物,开展复原力分层试验,整合心血管肿瘤监测,并实施精确的支持性护理模型,将压力、炎症和复原力指标结合起来,以优化高危人群的肿瘤和心血管预后。
{"title":"Stress, inflammation, and resilience among patients with oral squamous cell carcinoma undergoing multimodal therapy: Current knowledge and future directions.","authors":"Tai-Chu Peng, Chun-Hou Huang, Yu-Fu Chou, Peir-Rong Chen","doi":"10.4103/tcmj.tcmj_208_25","DOIUrl":"https://doi.org/10.4103/tcmj.tcmj_208_25","url":null,"abstract":"<p><p>Oral squamous cell carcinoma represents a significant public health challenge in Asia, where multimodal therapies, while extending survival, impose substantial biologic and psychosocial stress. Sustained activation of the sympathetic-adrenal-medullary axis and dysregulation of the hypothalamic-pituitary-adrenal axis increase catecholamines, cortisol, interleukin-6, and C-reactive protein, accelerating tumor progression, impairing treatment tolerance, and increasing cardiovascular risk. Betel quid chewing, prevalent in the region, exacerbates inflammation and contributes to cardiovascular comorbidities. Resilience, defined as the ability to restore physiologic and emotional homeostasis, modulates these pathways, with higher resilience linked to improved recovery, quality of life, and survival. Current evidence supports interventions including structured psychoeducation, cognitive-behavioral therapy, and peer mentoring to reduce anxiety and enhance treatment adherence. Smoking and betel quid cessation, alongside cardiometabolic optimization, mitigate inflammatory burden. Nonopioid strategies, including acupuncture, transcutaneous vagus nerve stimulation, and mindfulness, recalibrate neuro-immune signaling while minimizing opioid reliance. Enhanced recovery surgical protocols and omega-3 supplementation attenuate inflammatory responses and preserve lean mass. Emerging biomarkers such as heart rate variability and neutrophil-lymphocyte ratio show promise for real-time stress and inflammation monitoring. Digital health technologies and telerehabilitation extend intervention benefits postdischarge. Future research should focus on validating predictive biomarkers, developing resilience-stratified trials, integrating cardio-oncology surveillance, and implementing precision supportive care models that incorporate stress, inflammation, and resilience metrics to optimize oncologic and cardiovascular outcomes in this high-risk population.</p>","PeriodicalId":45873,"journal":{"name":"Tzu Chi Medical Journal","volume":"38 1","pages":"59-67"},"PeriodicalIF":1.6,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12885460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146158762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tzu Chi Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1